Replimune Group Inc (REPL) concluded trading on Thursday at a closing price of $7.66, with 2.66 million shares of worth about $20.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -59.26% during that period and on Thursday the price saw a gain of about 11.50%. Currently the company’s common shares owned by public are about 56.68M shares, out of which, 45.07M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 36 times over the past 12 months. They bought 571,088 shares in 16 of the transactions. In 20 selling transactions, insiders dumped 159,192 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the stock later moved at a day high price of 7.79, or with a gain of 11.50%. Stock saw a price change of -0.78% in past 5 days and over the past one month there was a price change of -4.96%. Year-to-date (YTD), REPL shares are showing a performance of -9.13% which decreased to -68.65% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.89 but also hit the highest price of $25.06 during that period. The average intraday trading volume for Replimune Group Inc shares is 1.92 million. The stock is currently trading 0.23% above its 20-day simple moving average (SMA20), while that difference is down -4.13% for SMA50 and it goes to -50.74% lower than SMA200.
Replimune Group Inc (NASDAQ: REPL) currently have 56.68M outstanding shares and institutions hold larger chunk of about 87.93% of that.
The stock has a current market capitalization of $470.25M and its 3Y-monthly beta is at 1.20. It has posted earnings per share of -$3.28 in the same period. It has Quick Ratio of 12.40 while making debt-to-equity ratio of 0.18. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for REPL, volatility over the week remained 8.09% while standing at 6.88% over the month.
Analysts are in expectations that Replimune Group Inc (REPL) stock would likely to be making an EPS of -$0.82 in the current quarter, while forecast for next quarter EPS is -$0.82 and it is -$3.08 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.86 which is -$0.77 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.74 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -3.57% while it is estimated to increase by 5.95% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on April 17, 2023 offering an Overweight rating for the stock and assigned a target price of $44 to it.
